Kyverna Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Kyverna Therapeutics Inc
TickerKYTX
CIK #0001994702
CUSIP501976104
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address5980 Horton Street Suite 550, Emeryville, CA 94608
Source [EDGAR]
CIK Filing 2011 - 2025
[0001994702] 10-K
[0001994702] 10-Q
[0001994702] 3
[0001994702] 4
[0001994702] 8-K
[0001994702] D
[0001994702] SC 13D
[0001994702] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Westlake Biopartners Fund I LP Kyverna Therapeutics Inc [2024-11-12] 8.8
JPMorgan Chase & Co Kyverna Therapeutics Inc [2024-10-10] 5.5
Vida Ventures LLC Kyverna Therapeutics Inc [2024-05-03] 11.0
Northpond Ventures III LP Kyverna Therapeutics Inc [2024-02-22] 1.0
Gilead Sciences Inc Kyverna Therapeutics Inc [2024-02-20] 8194.0
Bain Capital Life Sciences Opportunities III LP Kyverna Therapeutics Inc [2024-02-14] 7.4
Form 3/4/5 Filer 2011 - 2025
Grasso Marc
Kyverna Therapeutics, Inc.
Seidenberg Beth C
Spiegelman Daniel K
Aktar Mert
Cohen Fred E
Clark Ian T
Shaw Christi
Walker Karen Marie
Biddle Warner Weston
Jones Ryan Alexander
Gehchan NAJI
Vida Ventures GP III, L.L.C.
Vida Ventures III-A, L.P.
Vida Ventures III, L.P.
Vida Ventures, LLC
Westlake BioPartners Fund I, L.P.
Westlake BioPartners Opportunity Fund I, L.P.
Harper Sean E
Westlake BioPartners GP I, LLC
Westlake BioPartners Opportunity GP I, LLC
Bain Capital Life Sciences Opportunities III, LP
Bain Capital Life Sciences Opportunities III GP, LLC
Bain Capital Life Sciences Investors, LLC
Bain Capital Life Sciences Fund III, L.P.
Bain Capital Life Sciences III General Partner, LLC
Gilead Sciences Inc
Northpond Ventures III, LP
Northpond Ventures III GP, LLC
Rubin Michael P.
Liapis Stephen Constantine
Borie Dominique Christian
Chung James Bum
Kotzin Brian L.
Maag Peter
Form 13F Holdings
Firm Period DFND Voting Shares
Vida Ventures Advisors LLC [2025-06-30] SOLE 4,523,924 4,523,924
Gilead Sciences Inc [2025-06-30] SOLE 4,126,119 4,126,119
Bain Capital Life Sciences Investors, LLC [2025-06-30] SOLE 3,368,370 3,368,370
Price T Rowe Associates Inc /MD/ [2025-06-30] SOLE 1,778,516 1,778,516
Vanguard Group Inc [2025-06-30] SOLE 0 1,306,596
Insight Holdings Group, LLC [2025-06-30] DFND 0 989,054
Franklin Resources Inc [2025-06-30] DFND 695,027 695,027
MBB Public Markets I LLC [2025-06-30] SOLE 614,477 614,477
Catalio Capital Management LP [2025-06-30] SOLE 586,909 586,909
BlackRock, Inc. [2025-06-30] SOLE 531,460 533,467
Millennium Management LLC [2025-06-30] SOLE 452,560 452,560
KERA Capital Partners Inc [2025-06-30] SOLE 0 421,924
Peapod Lane Capital LLC [2025-06-30] SOLE 316,615 396,763
Citadel Advisors LLC [2025-06-30] DFND 364,689 364,689
Geode Capital Management LLC [2025-06-30] DFND 287,601 287,601
TD Asset Management Inc [2025-06-30] SOLE 252,196 252,196
Morgan Stanley [2025-06-30] DFND 149,008 202,038
Cubist Systematic Strategies, LLC [2025-06-30] DFND 0 144,623
Superstring Capital Management LP [2025-06-30] SOLE 142,542 142,542
Goldman Sachs Group Inc [2025-06-30] DFND 136,378 136,378
Renaissance Technologies LLC [2025-06-30] SOLE 122,417 122,417
Two Sigma Investments LP [2025-06-30] SOLE 120,584 120,584
Charles Schwab Investment Management Inc [2025-06-30] SOLE 118,606 118,606
Manufacturers Life Insurance Company the [2025-06-30] DFND 118,297 118,297
Susquehanna International Group LLP [2025-06-30] OTR 72,269 100,869
UBS Group AG [2025-06-30] DFND 97,562 98,158
AQR Capital Management LLC [2025-06-30] DFND 98,133 98,133
Two Sigma Advisers LP [2025-06-30] SOLE 90,200 94,300
State Street Corp [2025-06-30] DFND 91,300 91,300
Jane Street Group LLC [2025-06-30] DFND 87,769 87,769
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com